Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers

Nature Genetics
Suna Onengut-GumuscuStephen S Rich

Abstract

Genetic studies of type 1 diabetes (T1D) have identified 50 susceptibility regions, finding major pathways contributing to risk, with some loci shared across immune disorders. To make genetic comparisons across autoimmune disorders as informative as possible, a dense genotyping array, the Immunochip, was developed, from which we identified four new T1D-associated regions (P < 5 × 10(-8)). A comparative analysis with 15 immune diseases showed that T1D is more similar genetically to other autoantibody-positive diseases, significantly most similar to juvenile idiopathic arthritis and significantly least similar to ulcerative colitis, and provided support for three additional new T1D risk loci. Using a Bayesian approach, we defined credible sets for the T1D-associated SNPs. The associated SNPs localized to enhancer sequences active in thymus, T and B cells, and CD34(+) stem cells. Enhancer-promoter interactions can now be analyzed in these cell types to identify which particular genes and regulatory sequences are causal.

References

Oct 28, 2003·Diabetes Care·Saul GenuthUNKNOWN Expert Committee on the Diagnosis and Classification of Diabetes Mellitus
Jun 29, 2004·Diabetes·Bryan J BarrattJohn A Todd
Sep 13, 2005·International Journal of Epidemiology·Chris Power, Jane Elliott
Jun 8, 2007·Nature·UNKNOWN Wellcome Trust Case Control Consortium
Dec 17, 2008·The New England Journal of Medicine·Deborah J SmythJohn A Todd
Jan 13, 2009·Diabetes·Patrick ConcannonUNKNOWN Type 1 Diabetes Genetics Consortium
May 12, 2009·Nature Genetics·Jeffrey C BarrettUNKNOWN Type 1 Diabetes Genetics Consortium
Sep 8, 2009·American Journal of Human Genetics·Wei-Min ChenStephen S Rich
Jul 7, 2010·Clinical Trials : Journal of the Society for Clinical Trials·Joan E HilnerUNKNOWN T1DGC
Jul 10, 2010·Bioinformatics·Cristen J WillerGonçalo R Abecasis
Oct 12, 2010·Bioinformatics·Ani ManichaikulWei-Min Chen
Oct 27, 2010·Genetic Epidemiology·Dmitri V Zaykin, Damian O Kozbur
Oct 29, 2010·Nature·Gonçalo R AbecasisGil A McVean
Aug 20, 2011·PLoS Genetics·Chris CotsapasUNKNOWN FOCiS Network of Consortia
Oct 4, 2011·Cell·Herbert W Virgin, John A Todd
Oct 8, 2011·PLoS Genetics·Jonathan P BradfieldHakon Hakonarson
Jul 4, 2012·Nature Genetics·Linda M BoettgerSteven A McCarroll
Sep 11, 2012·Nature Genetics·Jimmy Z LiuUNKNOWN Wellcome Trust Case Control Consortium 3
Oct 30, 2012·Nature Genetics·UNKNOWN Wellcome Trust Case Control ConsortiumPeter Donnelly
Dec 10, 2013·Nucleic Acids Research·Danielle WelterHelen Parkinson
Jan 15, 2014·Nature Genetics·Lorenzo PasqualiJorge Ferrer
Mar 29, 2014·Nature·Robin AnderssonAlbin Sandelin

❮ Previous
Next ❯

Citations

Jul 21, 2015·American Journal of Human Genetics·Gleb Kichaev, Bogdan Pasaniuc
Jan 23, 2016·Diabetes·Judith E FradkinGriffin P Rodgers
Dec 25, 2015·Diabetologia·Susanne M CabreraMartin J Hessner
Jun 24, 2015·Clinical and Experimental Immunology·L S K Walker, M von Herrath
Oct 10, 2015·Molecular and Cellular Endocrinology·Simranjeet KaurUNKNOWN Hvidoere International Study Group
Dec 2, 2015·Nature Genetics·Constantin Polychronakos, Maha Alriyami
Sep 9, 2015·Journal of Autoimmunity·Masaki TakeuchiElaine F Remmers
Aug 11, 2015·Journal of Autoimmunity·Katrina M de Lange, Jeffrey C Barrett
Jul 1, 2015·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Niels V RekersJohnna D Wesley
Oct 12, 2015·Current Diabetes Reports·Jeffrey D RoizenHakon Hakonarson
Mar 30, 2016·Nature Reviews. Endocrinology·Anne Op de Beeck, Decio L Eizirik
Jul 15, 2015·Human Molecular Genetics·Sarah L Spain, Jeffrey C Barrett
Jun 30, 2015·Scandinavian Journal of Immunology·M T HeinonenR Lahesmaa
Jun 20, 2015·International Journal of Immunogenetics·J KianiG Solgi
Aug 25, 2015·Frontiers in Genetics·Divya Sri Priyanka TallapragadaGiriraj R Chandak
Aug 15, 2015·Current Diabetes Reports·Michael L StitzelDuygu Ucar
Apr 16, 2016·International Journal of Immunogenetics·P GerasimouP Costeas
Jun 2, 2015·The Journal of Clinical Investigation·Alexander MarsonDavid A Hafler
Jun 16, 2016·Lancet·Flemming Pociot, Åke Lernmark
Jul 15, 2016·Pediatric Diabetes·Flemming PociotLotte B Nielsen
Oct 30, 2016·Translational Research : the Journal of Laboratory and Clinical Medicine·Fraser W ScottJennifer A Crookshank
Nov 4, 2016·Science Translational Medicine·Calliope A DendrouLars Fugger
Nov 15, 2016·Nature Reviews. Genetics·Bogdan Pasaniuc, Alkes L Price
Nov 22, 2016·Nature Reviews. Genetics·Stefan H StrickerStephan Beck
Oct 21, 2016·Journal of Thrombosis and Haemostasis : JTH·I ManciniUNKNOWN Italian Group of TTP Investigators
Dec 3, 2016·Nucleic Acids Research·Jacqueline MacArthurHelen Parkinson
Jan 25, 2017·Trends in Molecular Medicine·Adrian ListonVasiliki Lagou

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping

Software Mentioned

Bioconductor
Ensembl
R package
R
snpS
ImmunoChip
KING
VEP
package
Blood eQTL browser

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.